Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients

Journal of Nephrology

Volumn 19, Issue 3, 2006, Pages 312-317

  Hu, Weixin ^a,b   Liu, Z ^a   Ji, D ^a   Xie, H ^a   Gong, D ^a   Li, L ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STAPHYLOCOCCUS PROTEIN A; ANTIBODY; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CHINESE; GOODPASTURE SYNDROME; HEMODIALYSIS; HUMAN; IMMUNOADSORPTION; KIDNEY FAILURE; LUNG HEMORRHAGE; MALE; MULTIPLE CYCLE TREATMENT; BLOOD; CHINA; DETOXIFICATION; FOLLOW UP; GLOMERULONEPHRITIS; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; CHINA; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SORPTION DETOXIFICATION; STAPHYLOCOCCAL PROTEIN A; TREATMENT OUTCOME;

EID: 33749053154     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999; 10: 2446-53.
2. Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1976; 1: 711-5.
3. Salama AD, Levy JB, Lightstone L, Pusey CD. Goodpasture's disease. Lancet 2001; 358: 917-20.
4. Yao XD, Tang Z, Chen HP, Wang QW, Hu WX, Liu M, Liu ZH, Li LS. Anti-glomerular basement membrane disease: an epidemicological analysis of 14 Chinese patients. Shenzangbing Yu Touxi Shenyizhi Zazhi 2001; 10: 211-7.
5. Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant 1994; 9: 372-6.
6. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134: 1033-42.
7. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet 1985; : 1295-6.
8. Moreso F, Poveda R, Gil-Vernet S, Carreras L, Garcia-Osuna R, Grino JM, Alsina J. [Therapeutic immunoadsorption in Goodpasture disease] [article in Spanish]. Med Clin (Barc) 1995; 105: 59-61.
9. Laczika K, Knapp S, Derfler K, Soleiman A, Horl WH, Druml W. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 2000; 36: 392-5.
10. Stegmayr B, Almroth G, Berlin G. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs 1999; 22: 81-7.
11. Chen HP, Zeng CH, Hu WX, Wang QW, Yu YS, Yao XD, Tang Z, Wang JP, Zhu MY, Zhou H, Liu H, Liu ZH, Li LS. Analysis of 10594 renal biopsy data. Shenzangbing Yu Touxi Shenyizhi Zazhi 2000; 9: 501-9.
12. Andrassy K, Kuster S, Waldherr R, Ritz E. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron 1991; 50: 206-12.
13. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Am Soc Nephrol 1999; 10: 1389-1404.
14. Braun N, Risler T, Ramlow W. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease. Ther Apher 1999; 3: 240-5.
15. Matic G, Boxdh T, Ramlow W. Background and indications for protein A-based extracorporeal immunoadsorption. Ther Apher 2001; 5: 394-403.
16. Hehmke B, Salzsieder E, Matic GB, Winkler RE, Tiess M, Ramlow W. Immunoadsorption of immunoglobins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases. Ther Apher 2000; 4: 296-302.
17. Hu WX, Liu ZH, Chen HP, Tang Z, Wang Q, Shen K, Li L. Mycophenolate mofetil vs cyclophosphamide therapy for diffuse proliferative lupus nephritis. Chin Med J 2002; 115: 705-9.